SCHEMBL7142298

SCHEMBL7142298

CCCCOC(=O)N1C[C@H](S)C[C@@H]1CCCc1ncc[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 1/20 0.41
TBXAS1 P24557 2/20 0.36
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
GBA2 Q9HCG7 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
LMNA P02545 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
NAMPT P43490 2/20 0.31
ITGB3 P05106 1/20 0.31
ITGB1 P05556 1/20 0.31
ITGAV P06756 1/20 0.31
ITGA2B P08514 1/20 0.31
ITGA5 P08648 1/20 0.31
AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5410369 0.77 ECE1 (0.43) ECE1OPRK1
SCHEMBL5422520 0.74 TBXAS1 (0.43) ECE1TBXAS1CYP19A1LMNA
SCHEMBL9216047 0.74 TBXAS1 (0.37) TBXAS1CYP19A1
SCHEMBL5412971 0.74 ECE1 (0.43) ECE1GBA2LMNAOPRD1OPRK1
SCHEMBL9369510 0.73 SIGMAR1 (0.32) ECE1CYP19A1
SCHEMBL9428575 0.72 ECE1 (0.44) ECE1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL5407269 0.67 ECE1 (0.52) ECE1CYP3A4LMNAOPRD1OPRK1
SCHEMBL31629521 0.66 SMN1; SMN2 (0.54) ECE1GBA2LMNAOPRD1OPRK1
SCHEMBL5401467 0.66 ECE1 (0.43) ECE1CYP2D6GBA2LMNA
SCHEMBL7142974 0.65 ECE1 (0.50) ECE1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303486-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
WO-2002008185-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-31 WO disclosed